ALTO NEUROSCIENCE INC
ANRO
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry therapeutics that use EEG brain biomarkers to match patients with treatments most likely to help them. Its pipeline includes ALTO-100 for bipolar depression in Phase 2b, ALTO-300 for major depressive disorder in Phase 2b, ALTO-101 for cognitive impairment in schizophrenia in Phase 2, and ALTO-207 for treatment-resistant depression heading toward a potentially pivotal Phase 2b trial in the first half of 2026. All drug candidates in the pipeline required preclinical animal pharmacology and toxicology studies to support IND filings under FDA regulations. ALTO-207, acquired from Chase Therapeutics in May 2025, underwent its own preclinical development program before entering human trials.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.